InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Tuesday, 04/18/2017 11:52:13 AM

Tuesday, April 18, 2017 11:52:13 AM

Post# of 8022
Looks like India stole the ACI idea

http://www.thehindubusinessline.com/news/science/repairing-painful-joints-rms-regrow-to-offer-cartilage-therapy-using-own-cells/article9640453.ece
Repairing painful joints: RMS Regrow to offer cartilage therapy using own cells

New Delhi, April 14:

If you, or any of your family members, suffer from painful joints, and have been recommended surgery, here’s some good news. A new therapy could help you continue with your life using your own cells to treat the problem.

A new cell therapy product, Chondron ACI (Autologous Chondrocyte Implantation), by Regenerative Medical Services (RMS) Regrow, has received a market authorisation approval from the Drug Controller General of India, the company’s Chief Executive Officer Yash Sanghavi told BusinessLine, adding that the company is the first in India and only the fourth globally to receive this approval.

The therapy, which has been available globally for years, would now be provided by RMS. Being the first to receive an approval from the drug controller would put the company in a position of advantage.

“We have data exclusivity for four years. We are in talks with a number of hospital chains to provide the treatment,” Satyen Sanghavi, Chief Scientific Officer and Executive Director of the company, said.

Satyen Sanghavi said the therapy involves a keyhole surgery into the patient’s knees to calculate the extent of damage to the cartilage, a small section of the cartilage is then harvested from the joint, and the cells cultured in a lab for about four weeks before being implanted into the damaged area.

“This is the only treatment for large defects and damages to the cartilage. It can help postpone the need for a replacement significantly and allow the patient to resume their normal routine in about three to six months,” he said.

The company aims to keep its therapy cost-effective and competitive compared with replacement surgeries. “If you see, the same treatment in the US offered by Carticel, costs about $20,000 (about ?12.9 lakh). We will offer the same at ?2 lakh, which is approximately the cost of a knee replacement,” Yash Sanghavi said.

https://www.dotemirates.com/en/details/3303676?from=dot

http://www.deccanchronicle.com/lifestyle/pets-and-environment/180417/is-it-possible-to-regrow-cartilage-and-avoid-replacement-surgeries-yes.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News